IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 194
Titolo Data di pubblicazione Autore(i) File
Erlotinib in cancer treatment 1-gen-2007 Bareschino, Ma; Schettino, C; Troiani, Teresa; Martinelli, Erika; Morgillo, Floriana; Ciardiello, Fortunato
Chemoradiotherapy as adjuvant treatment of gastric cancer 1-gen-2007 Orditura, Michele; Martinelli, Erika; Galizia, Gennaro; Vitiello, F; Fasano, M; Muto, P; Ciardiello, Fortunato; DE VITA, Ferdinando
Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer 1-gen-2007 Martinelli, Erika; Morgillo, Floriana; Troiani, Teresa; Tortora, G; Cairdiello, F.
Combination of anti-EGFR drugs and other molecular targeted agents as anti-cancer strategy 1-gen-2007 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Tortora, G; Ciardiello, Fortunato
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. 1-gen-2008 Tabernero, J; Rojo, F; Calvo, E; Burris, H; Judson, I; Hazell, K; Martinelli, Erika; Ramon y. Cajal, S; Jones, S; Vidal, L; Shand, N; Macarulla, T; Ramos, Fj; Zoellner, U; Tang, P; Stumm, M; Lane, Ha; Lebwohl, D; Baselga, J.
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells 1-gen-2008 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Laus, G; Pepe, S; Gridelli, C; Ciardiello, Fortunato
The use of xenograft models for the selection of cancer treatments with the EGFR as an example 1-gen-2008 Troiani, Teresa; Schettino, C; Martinelli, Erika; Morgillo, Floriana; Tortora, G; Ciardiello, Fortunato
Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report 1-gen-2008 Vitiello, F; Ricci, V; Martinelli, Erika; Orditura, Michele; DE VITA, Ferdinando; Galizia, Gennaro; Ciardiello, Fortunato
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 1-gen-2009 Orditura, Michele; DE VITA, Ferdinando; Galizia, Gennaro; Lieto, Eva; Vecchione, L; Vitiello, F; Martinelli, Erika; Ciardiello, Fortunato
Resistance mechanisms of tumour cells to EGFR inhibitors 1-gen-2009 Morgillo, Floriana; Cantile, F; Fasano, M; Troiani, Teresa; Martinelli, Erika; Ciardiello, Fortunato
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 1-gen-2009 Martinelli, Erika; DE PALMA, Raffaele; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study 1-gen-2009 Tabernero, J; Ciardiello, Fortunato; Rivera, F; RODRIGUEZ BRAUN, E; Ramos, Fj; Martinelli, Erika; VEGA VILLEGAS, Me; Roselló, S; Liebscher, S; Kisker, O; Macarulla, T; Baselga, J; Cervantes, A.
Dual inhibitor AEE788 reduces tumor growth in preclinical models of medulloblastoma 1-gen-2010 Meco, D.; Servidei, T.; Zannoni, G. F.; Martinelli, E.; Prisco, M. G.; de Waure, C.; Riccardi, R.
Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors. 1-gen-2010 Baselga, J; Cervantes, A; Martinelli, Erika; Chirivella, I; Hoekman, K; Hurwitz, Hi; Jodrell, Di; Hamberg, P; Casado, E; Elvin, P; Swaisland, A; Iacona, R; Tabernero, J.
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 1-gen-2010 Orditura, Michele; DE VITA, Ferdinando; Muto, P; Vitiello, F; Murino, P; Lieto, Eva; Vecchione, L; Romano, A; Martinelli, Erika; Renda, A; Ferraraccio, Franca; DEL GENIO, A; Ciardiello, Fortunato; Galizia, Gennaro
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 1-gen-2010 Martinelli, Erika; Troiani, Teresa; Morgillo, Floriana; Rodolico, G; Vitagliano, D; Morelli, Mp; Tuccillo, C; Vecchione, L; Capasso, A; Orditura, Michele; DE VITA, Ferdinando; Eckhardt, Sg; Santoro, M; Berrino, Liberato; Ciardiello, Fortunato
Pharmacogenomic and pharmacoproteomic studies of cetuximab in metastatic colorectal cancer: biomarker analysis of a phase I dose-escalation study 1-gen-2010 Tabernero, J; Cervantes, A; Rivera, F; Martinelli, Erika; Rojo, F; VON HEYDEBRECK, A; Macarulla, T; RODRIGUEZ BRAUN, E; EUGENIA VEGA VILLEGAS, M; Senger, S; Ramos, Fj; Roselló, S; Celik, I; Stroh, C; Baselga, J; Ciardiello, Fortunato
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: A phase II study 1-gen-2010 Orditura, Michele; Galizia, Gennaro; Napolitano, Vincenzo; Martinelli, Erika; Pacelli, R; Lieto, Eva; Aurilio, G; Vecchione, L; Morgillo, Floriana; Catalano, G; Ciardiello, Fortunato; DEL GENIO, A; DE VITA, Ferdinando
TRASTUZUMAB RESISTANCE IN BREAST CANCER 1-gen-2011 Morgillo, Floriana; Orditura, Michele; Troiani, Teresa; Martinelli, Erika; DE VITA, Ferdinando; Ciardiello, Fortunato
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 1-gen-2011 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato; Ciardiello, F.
Mostrati risultati da 21 a 40 di 194
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile